Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Glotzer, D. E.
Right arrow Articles by Bauchner, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glotzer, D. E.
Right arrow Articles by Bauchner, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Management of Childhood Lead Poisoning

Clinical Impact and Cost-Effectiveness

Deborah E. Glotzer, MD, MPH

Kenneth A. Freedberg, MD, MSc

Howard Bauchner, MD

Objectives. No consensus exists regarding the preferred treatment of childhood lead poi soning. The authors used decision analysis to compare the clinical impacts and cost-ef fectiveness of four management strategies for childhood lead poisoning, and to investigate how effective chelation therapy must be in reducing neuropsychologic sequelae to warrant its use. Methods. The model was based on a 2-year-old child with moderate lead poisoning [blood lead level 1.21 to 1.88 µmol/L (25 to 39 µg/dL)]. The following strategies were compared: 1) no treatment; 2) EDTA provocation testing, followed by chelation if testing is positive (PROV); 3) penicillamine chelation with crossover to EDTA provocation testing if toxicity occurs (PCA); 4) EDTA provocation testing with crossover to penicillamine chelation if testing is negative (EDTA). Results. The EDTA and PCA strategies prevented 22.5% of the cases of reading disability and resulted in an increase of 1.02 quality-adjusted life years compared with no treatment. When the costs of outpatient EDTA testing and chelation are considered, the EDTA strategy is more cost-effective than the PCA strategy; when inpatient costs are considered, the PCA strategy becomes more cost-effective. When costs of remedial education are considered, all strategies are cost-saving compared with no treatment if che lation reduces the risk of lead-induced reading disability by more than 20%. Conclusions. Treatment strategies for childhood lead poisoning vary in clinical impact, cost, and cost- effectiveness. Chelation of the 1.4% of United States preschoolers whose blood lead levels are 1.21 µmol/L (25 µg/dL) or higher could prevent more than 45,000 cases of reading disability, and save more than $900 million per year in overall costs when the costs of remedial education are considered. Key words: lead poisoning; decision analysis; cost anal ysis ; chelation. (Med Decis Making 1995;15:13-24)

Medical Decision Making, Vol. 15, No. 1, 13-23 (1995)
DOI: 10.1177/0272989X9501500104


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
N. B. Jain, F. Laden, U. Guller, A. Shankar, S. Kazani, and E. Garshick
Relation between Blood Lead Levels and Childhood Anemia in India
Am. J. Epidemiol., May 15, 2005; 161(10): 968 - 973.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
I. Griebsch, J. Coast, and J. Brown
Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility Studies in Child Health
Pediatrics, May 1, 2005; 115(5): e600 - e614.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
M. J. Brown
Costs and Benefits of Enforcing Housing Policies to Prevent Childhood Lead Poisoning
Med Decis Making, December 1, 2002; 22(6): 482 - 492.
[Abstract] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
A. R. Kemper, W. C. Bordley, and S. M. Downs
Cost-effectiveness Analysis of Lead Poisoning Screening Strategies Following the 1997 Guidelines of the Centers for Disease Control and Prevention
Arch Pediatr Adolesc Med, December 1, 1998; 152(12): 1202 - 1208.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
R. Casey, C. Wiley, R. Rutstein, and J. Pinto-Martin
Longitudinal Assessment for Lead Poisoning
Clinical Pediatrics, February 1, 1996; 35(2): 58 - 61.
[Abstract] [PDF]